Please login to the form below

Not currently logged in
Email:
Password:

recognition

This page shows the latest recognition news and features for those working in and with pharma, biotech and healthcare.

Another day, another Brexit delay – so what happens now?

Another day, another Brexit delay – so what happens now?

Health Secretary Matt Hancock (pictured right) told the Bioscience Forum earlier this month that the intention is for regulatory collaboration with the EMA to continue, including mutual recognition of products produced

Latest news

More from news
Approximately 1 fully matching, plus 356 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 59 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 20 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 111 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics